-
2
-
-
24344444078
-
Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment
-
Hero M., Jänne O.A., Näntö-Salonen K., et al. Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment. J Clin Endocrinol Metab 2005, 90:5141.
-
(2005)
J Clin Endocrinol Metab
, vol.90
, pp. 5141
-
-
Hero, M.1
Jänne, O.A.2
Näntö-Salonen, K.3
-
3
-
-
0034031258
-
Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)
-
Müderris, Bayram F., Güven M. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day). Gynecol Endocrinol 2000, 14:38.
-
(2000)
Gynecol Endocrinol
, vol.14
, pp. 38
-
-
Müderris1
Bayram, F.2
Güven, M.3
-
4
-
-
34548799898
-
Spanish Working Group for Hirsutism: Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial
-
Calaf J., López E., Millet A., et al. Spanish Working Group for Hirsutism: Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007, 92:3446.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 3446
-
-
Calaf, J.1
López, E.2
Millet, A.3
-
5
-
-
4344566243
-
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide
-
Ibáñez L., Valls C., Cabré S., et al. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. J Clin Endocrinol Metab 2004, 89:4716.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 4716
-
-
Ibáñez, L.1
Valls, C.2
Cabré, S.3
-
6
-
-
68949204550
-
Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months
-
Ibáñez L., López-Bermejo A., Díaz M., et al. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months. Clin Endocrinol 2009, 71:351.
-
(2009)
Clin Endocrinol
, vol.71
, pp. 351
-
-
Ibáñez, L.1
López-Bermejo, A.2
Díaz, M.3
-
7
-
-
64549090025
-
Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety
-
de Zegher F., Ibáñez L. Low-dose flutamide for women with androgen excess: anti-androgenic efficacy and hepatic safety. J Endocrinol Invest 2009, 32:83.
-
(2009)
J Endocrinol Invest
, vol.32
, pp. 83
-
-
de Zegher, F.1
Ibáñez, L.2
-
8
-
-
64549127776
-
A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
-
Unluhizarci K., Ozel D., Tanriverdi F., et al. A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism. J Endocrinol Invest 2009, 32:37.
-
(2009)
J Endocrinol Invest
, vol.32
, pp. 37
-
-
Unluhizarci, K.1
Ozel, D.2
Tanriverdi, F.3
|